United States v. Berroa-Medrano ( 2002 )


Menu:
  •                                                                                                                            Opinions of the United
    2002 Decisions                                                                                                             States Court of Appeals
    for the Third Circuit
    9-6-2002
    USA v. Berroa-Medrano
    Precedential or Non-Precedential: Precedential
    Docket No. 01-2212
    Follow this and additional works at: http://digitalcommons.law.villanova.edu/thirdcircuit_2002
    Recommended Citation
    "USA v. Berroa-Medrano" (2002). 2002 Decisions. Paper 555.
    http://digitalcommons.law.villanova.edu/thirdcircuit_2002/555
    This decision is brought to you for free and open access by the Opinions of the United States Court of Appeals for the Third Circuit at Villanova
    University School of Law Digital Repository. It has been accepted for inclusion in 2002 Decisions by an authorized administrator of Villanova
    University School of Law Digital Repository. For more information, please contact Benjamin.Carlson@law.villanova.edu.
    PRECEDENTIAL
    Filed September 6, 2002
    UNITED STATES COURT OF APPEALS
    FOR THE THIRD CIRCUIT
    No. 01-2212
    UNITED STATES OF AMERICA
    v.
    JUAN D. BERROA-MEDRANO
    a/k/a KALIN
    a/k/a JOSE RAFAEL RIVERO
    Jose Rivero,
    Appellant
    On Appeal from the United States District Court
    for the Eastern District of Pennsylvania
    (Crim. No. 97-00641-02)
    District Judge: The Honorable James McGirr Kelly
    Argued February 25, 2002
    Before: ROTH, FUENTES and GIBSON,* Circuit Jud ges
    (Opinion Filed: September 6, 2002)
    PAUL J. HETZNECKER, ESQ.
    1420 Walnut Street
    Suite 911
    Philadelphia, PA 19102
    Attorney for Appellant
    _________________________________________________________________
    * The Honorable John R. Gibson, United States Circuit Judge for the
    Eighth Circuit, sitting by designation.
    PATRICK L. MEEHAN
    United States Attorney
    LAURIE MAGID
    Deputy United States Attorney
    for Policy and Appeals
    ROBERT A. ZAUZMER (argued)
    Assistant United States Attorney
    Senior Appellate Counsel
    BARBARA J. COHAN
    Assistant United States Attorney
    615 Chestnut Street
    Suite 1250
    Philadelphia, Pennsylvania 19106
    Attorneys for Appellees
    OPINION OF THE COURT
    FUENTES, Circuit Judge:
    This case requires us to consider what constitutes a
    "mixture or substance containing a detectable amount" of a
    controlled substance for purposes of sentencing. Pursuant
    to a plea agreement, defendant Juan Berroa-Medrano
    ("Berroa") pled guilty to a single count of conspiracy to
    distribute heroin, but reserved the right to challenge at
    sentencing the weight of the heroin in question. At
    sentencing, although one of the two packages Berroa
    admitted to distributing contained mostly drug cutting
    agents and only trace amounts of heroin, the court used
    the total weight of the two packages as the basis to
    sentence Berroa to a 100-month prison term. On appeal,
    Berroa challenges the sentence on the grounds that the
    court improperly considered the gross weight of the two
    packages, about 1 kilogram, rather than the net weight of
    the heroin itself. Because we conclude that the District
    Court was entitled to consider the entire weight of any
    mixture or substance that contained a trace amount of
    heroin, we affirm.
    2
    I.
    A.
    The facts of this case are fairly straightforward. Berroa
    entered into an agreement with his co-defendant Mustafa
    Alabed to sell an undetermined amount of heroin to an
    individual who was actually a confidential informant. On
    October 28, 1997, the informant, equipped with a wireless
    transmitter, met with Alabed to arrange for the purchase of
    one kilogram of heroin.
    The informant and Alabed met inside Alabed’s carpet
    store in Philadelphia, and then, to complete the
    transaction, walked across the street to a building that
    Alabed was renovating. Inside the building, the two men
    met Berroa, who was holding a cereal box. Berroa handed
    the box to the informant, who opened it and found that it
    contained two separately wrapped packages, one large and
    one small, each containing an off-white substance that
    appeared to be heroin. The informant inspected the
    packages without removing the contents, and returned the
    box to Berroa, asking the defendants whether the heroin
    was from the same batch as a sample that had been given
    to him earlier in the day by Alabed. Alabed assured him
    that it was. The informant left the building, ostensibly to
    retrieve the payment for the heroin, but instead informed
    the drug enforcement agents of what had transpired. When
    he informed them that he believed Berroa was carrying a
    gun, the agents decided to wait for backup. Before backup
    arrived, however, Berroa fled the scene.
    Once the backup officers arrived, Alabed was arrested
    and the cereal box containing the two packages of off-white
    powder was seized. The larger of the packages, which was
    approximately the size and shape of a kilo of heroin, was
    field-tested by the agents with negative results for the
    presence of heroin. However, the smaller package, which
    was on top of the larger one inside the cereal box, field-
    tested positive for heroin. The smaller package contained
    slightly more than one ounce of off-white powder.
    Subsequent laboratory analysis disclosed that the larger
    package weighed slightly less than one kilogram (983.9
    3
    grams) and was comprised almost exclusively of procaine
    and lidocaine, common heroin cutting agents. The lab also
    determined that the larger package contained traces of
    heroin, but the purity of the drug could not be determined
    due to its small quantity. The smaller package, weighing 32
    grams, contained a similar mix of cutting agents, but with
    heroin detected at a purity of 3%.
    B.
    On December 3, 1997, a federal grand jury indicted
    Berroa, in absentia, along with Alabed, and charged him
    with conspiracy to distribute heroin in violation of 21
    U.S.C. S 846; distribution of heroin in violation of 21 U.S.C.
    S 841(a)(1) and 18 U.S.C. S 2; and distribution of heroin
    near a school in violation of 21 U.S.C. SS 860(a) and 841(a)(1).1
    Berroa was further charged with using and carrying a
    firearm in connection with a drug trafficking offense in
    violation of 18 U.S.C. S 924(c). Berroa was arrested
    approximately one year later in December 1998, in
    Camden, New Jersey, on state criminal charges unrelated
    to the instant case. Thereafter, he was removed to the
    Eastern District of Pennsylvania to face the federal
    indictment.
    On February 22, 1999, Berroa pled guilty, pursuant to a
    written plea agreement, to a single count of a superseding
    information charging distribution of heroin in violation of
    21 U.S.C. S 841(a)(1).2 The plea agreement provided for
    dismissal of the remaining charges. Additionally, Berroa’s
    plea agreement contained a provision stating that the
    parties "have not agreed on the quantity of drugs on which
    the defendant’s sentence should be calculated under[the
    relevant sentencing guidelines], and reserve their right to
    _________________________________________________________________
    1. Alabed later pled guilty to a single count of distribution of heroin, in
    violation of 21 U.S.C. S 841(a)(1), and was sentenced to 60 months
    imprisonment followed by a five-year term of supervised release.
    2. 21 U.S.C. S 841(a)(1) states, in relevant part, that "it shall be unlawful
    for any person knowingly or intentionally . . . to manufacture, distribute,
    or dispense, or [to] possess with intent to manufacture, distribute, or
    dispense, a controlled substance."
    4
    present their respective positions to the Court and
    Probation Department." App. Br. at 4.
    On May 2, 2001, the District Court sentenced Berroa.
    The District Court concluded that under the United States
    Sentencing Guidelines, the entire contents of each package
    must be included in calculating Berroa’s sentence. The
    court therefore determined that Berroa’s offense conduct
    involved more than one kilogram of heroin, and that,
    accordingly, Berroa’s sentencing guideline range was 168-
    210 months. However, because of the unusually low purity
    of the drug, the court granted Berroa a downward
    departure under U.S.S.G. S 2D1.1(b)(6), and sentenced him
    to 100 months imprisonment, 5 years supervised release,
    and a fine of $2,500.3 Berroa timely appealed.
    II.
    We have jurisdiction to review Berroa’s sentence
    pursuant to 28 U.S.C. S 1291. We review de novo a district
    court’s application of the Sentencing Guidelines. United
    States v. Henry, 
    282 F.3d 242
    , 246 (3d Cir. 2002).
    _________________________________________________________________
    3. Application Note 9 to U.S.S.G. S 2D1.1 specifically indicates that an
    upward departure may be appropriate where the controlled substance is
    of an unusually high purity. The comment further explains that the
    purity of a controlled substance, "particularly in the case of heroin, may
    be relevant in the sentencing process because it is probative of the
    defendant’s role or position in the chain of distribution." Given the
    Sentencing Commission’s omission of any discussion of a downward
    departure for low drug purity, some courts have decided that a
    downward departure is permissible while others have disagreed. Compare
    United States v. Mikaelian, 
    168 F.3d 380
    , 390 (9th Cir. 1999) (stating
    that "the low purity of heroin involved in a crime cannot be categorically
    excluded as a basis for a downward departure"), with United States v.
    Upthegrove, 
    974 F.2d 55
    , 56-57 (7th Cir. 1992) (holding that "downward
    departure based on the low quality of the relevant drug is improper"
    partly because the Application Notes contain "no corresponding provision
    suggesting a downward departure for low quality drugs").
    In this case, the Government acknowledged the District Court’s
    discretion to depart downward based on low purity and does not
    challenge the exercise of the Court’s discretion in this regard on appeal.
    Gov’t Br. at 28-29 & n.10. Accordingly, we need not reach this issue
    here.
    5
    III.
    A.
    The District Court calculated Berroa’s sentence using the
    Drug Quantity Table, subsection (c) of U.S.S.G.S 2D1.1.4
    Application Note (A) of the "Notes to Drug Quantity Table"
    provides that, "[u]nless otherwise specified, the weight of a
    controlled substance set forth in the table refers to the
    entire weight of any mixture or substance containing a
    detectable amount of the controlled substance" U.S.
    Sentencing Guidelines Manual S 2D1.1(c), cmt. n.A.
    (emphasis added). The language is derived from the
    mandatory minimum sentence provision of the statute
    under which Berroa was convicted. Section 841(b) provides
    minimum penalties for anyone violating S 841(a), including
    "100 grams or more of a mixture or substance containing a
    detectable amount of heroin" 21 U.S.C. S 841(b)(1)(B)(i)
    (emphasis added). The District Court examined this
    language and determined that, under the circumstances of
    Berroa’s case, it was required to include the combined
    weight of both packages in calculating Berroa’s sentence.
    The judge commented that, although it was "unusual" in
    his experience that a lab was "unable to determine the
    purity of [the drug in question,]" he could not "ignore [that]
    . . . [t]here was a detectable amount of a[controlled]
    substance" in the larger package. App. at A46. Therefore,
    the court determined that Berroa’s base offense level,
    including a 2-step increase for obstruction of justice based
    on a false identity charge, was 34, resulting in a guideline
    range of 168-210 months imprisonment.5
    _________________________________________________________________
    4. U.S.S.G. S 2D1.1 establishes the base offense level for offenses
    involving the "Unlawful Manufacturing, Importing, Exporting, or
    Trafficking" of controlled substances, and includes possession with the
    intent to commit these felonies.
    5. Conversely, if the court had decided to include only the contents of the
    smaller package, or even the contents of the smaller package along with
    the net weight of the heroin in the larger package, Berroa’s base offense
    level, considering his criminal history category of II, would have been 18.
    Even with a 2-step increase for obstruction of justice, Berroa’s sentence
    would have been significantly reduced to 30-37 months.
    6
    The District Court was not without precedent in deciding
    to include the entire contents of the larger, highly
    adulterated package in sentencing Berroa. For example,
    this Court recently determined that, even when a drug
    contains a very slight amount of a controlled substance, the
    entire package must count toward a defendant’s sentence.
    See United States v. Butch, 
    256 F.3d 171
    , 177-80 (3d Cir.
    2001) (instructing that the District Court must include the
    gross weight of Endocet pills in calculating a defendant’s
    mandatory minimum sentence under S 841(b), even though
    the controlled substance (oxycodone) in the pills was merely
    0.8% of the total weight of the pills; see also United States
    v. Touby, 
    909 F.2d 759
    , 772-73 (3d Cir. 1990) (holding that
    the entire weight of 100-gram slab of Euphoria must be
    considered by sentencing court, even though the controlled
    substance only comprised 2.7% of the total weight); United
    States v. Buggs, 
    904 F.2d 1070
    , 1077, 1079-80 (7th Cir.
    1990) (upholding sentence under S 841(b) for mixture
    containing 1.2% heroin). Nevertheless, Berroa attempts to
    distinguish his case by arguing that an immeasurably small
    "trace" of a controlled substance, together with an
    overwhelming amount of cutting agent, is neither a
    "mixture" nor a "substance," either as those terms are
    commonly understood or as intended by the statute or the
    Sentencing Guidelines.
    The Supreme Court has observed that since the terms
    "mixture" and "substance" have "not been defined in the
    statute or the Sentencing Guidelines and [have] no
    distinctive common-law meaning," they should be
    "construed . . . to have their ordinary meaning." Neal v.
    United States, 
    516 U.S. 284
    , 289 (1996) (citing Chapman v.
    United States, 
    500 U.S. 453
    , 461-62 (1991)). In Chapman,
    the Supreme Court analyzed a provision of the
    Comprehensive Drug Abuse Prevention and Control Act, 21
    U.S.C. S 841, et seq., that calls for a mandatory minimum
    sentence of five years for the distribution of any"mixture or
    substance" containing LSD that weighed one gram or more.
    Chapman 
    500 U.S. at 455
     (quoting 21 U.S.C.
    S 841(b(1)(B)(v)). The question before the Court was
    whether, for sentencing purposes, the weight of LSD should
    also include the blotter paper that is routinely sold with
    LSD. 
    Id. at 458
    . The Chapman court reasoned that,
    7
    because the LSD was "diffused among the fibers of the
    paper . . . [and] cannot be distinguished from the blotter
    paper nor easily separated from it," the entire package
    constituted a mixture, and therefore, the total weight of the
    blotter paper along with the absorbed LSD must be
    considered under the statute. 
    Id. at 462
    .
    Like the LSD and blotter paper in Chapman, the traces of
    heroin in the package used to sentence Berroa were
    diffused within the procaine and lidocaine, and the heroin
    could neither be distinguished nor easily separated from
    the contents of the package. Thus, the entire contents of
    the larger of the two packages used to sentence Berroa
    appears to satisfy the criteria identified by the Chapman
    court for identifying a "mixture" or a "substance."
    Nevertheless, Berroa attempts to distinguish his case
    from Chapman by relying on this court’s decision in United
    States v. Rodriguez, 
    975 F.2d 999
     (3d Cir. 1992). In
    Rodriguez, the defendants had taped a thin layer of cocaine
    (approximately 65 grams) over a much heavier block of
    boric acid (approximately 3 kilograms) and, attempting to
    pass the entire package off as 3 kilograms of cocaine, sold
    this block to undercover government agents as a"gag bag."6
    This Court held that, unlike the blotter paper/LSD mixture
    in Chapman, the sentencing court in Rodriguez should have
    excluded the weight of the boric acid, and only considered
    the weight of the much lighter cocaine in calculating the
    defendant’s base offense level under U.S.S.G. S 2D1.1.
    Rodriguez, 
    975 F.2d at 1007
    .
    Berroa argues that, like the defendants in Rodriguez, he
    did not actually intend to sell a kilo of heroin to the
    informant, but rather meant to "rip him off " by selling him
    a highly diluted "gag bag." He claims that the
    immeasurably small amount of heroin in the larger package
    proves this intent. Therefore, he concludes that as in
    Rodriguez, the sentencing court should not consider the
    weight of the non-controlled substances in calculating his
    sentence.
    _________________________________________________________________
    6. "Gag bag" is street parlance for a highly diluted or completely fake
    container of drugs. Gov’t Br. at 14-15.
    8
    However, Berroa’s reading of this Court’s holding in
    Rodriguez is too narrow. In Rodriguez, this Court placed as
    much emphasis on the plain meaning of the term
    "mixture," in the context of that case, as it did on the intent
    of the seller. The Rodriguez court observed that, unlike the
    circumstances in Chapman, in their case: 1) the boric acid
    and the cocaine remained distinct although in close
    proximity; 2) the boric acid was not being used as a cutting
    agent; 3) the boric acid, being highly toxic, was not
    intended to be consumed; and, 4) the boric acid did not
    facilitate the distribution of cocaine. 
    Id. at 1004-05
    . Relying
    on these characteristics, we concluded that the
    combination of cocaine and boric acid did not constitute a
    "mixture or substance" as contemplated by the Sentencing
    Commission in promulgating S 2D1.1, and that the clear
    intent of the seller was to use the cocaine "only to
    effectuate the scam by masking the identity of the boric
    acid blocks." 
    Id. at 1006
    .
    Berroa’s case is clearly distinguishable. First, the trace of
    heroin in the larger package was not "distinct although in
    close proximity," but instead was inextricably combined
    with the procaine and lidocaine. Second, while Berroa may
    argue that the procaine and the lidocaine in the larger
    package were not truly used as cutting agents but simply
    used to trick the buyer into buying a "gag bag," procaine
    and lidocaine are among the most common cutting agents
    for street heroin. See Hurtado v. United States , 
    2001 WL 135742
     at *1 (E.D.N.Y. 2001). Indeed, we note that this
    Court and other courts of appeals have upheld sentences
    for distribution of a controlled substance where procaine
    and/or lidocaine were part of the "cut." See, e.g., United
    States v. Agee, 
    597 F.2d 350
    , 352 (3d Cir. 1979) (upholding
    conviction for sale of heroin that had been diluted with
    "quinine, procaine and reducing sugar"); United States v.
    Nelson, 
    499 F.2d 965
    , 966 (8th Cir. 1974) (affirming
    conviction for distribution of heroin "laced with procaine
    and lactose, the latter two being cutting powders").
    Furthermore, neither one of these common cutting agents
    is toxic, and each is regularly "consumed" by the
    purchasers of heroin in the normal course of using the
    drug. See United States v. Gray, 
    982 F.2d 1020
    , 1021 (6th
    Cir. 1993) (noting that, at trial, the defendant had admitted
    9
    to using lidocaine in order "to adulterate cocaine for human
    consumption"). Finally, the presence of the procaine and
    lidocaine was intended to "facilitate the sale of[a controlled
    substance]," since pure heroin would likely be toxic to most
    any user. See Harrison’s Principles of Internal Medicine
    2567 (Eugene Brumwald et. al. eds., 15th ed. 2001).
    Clearly, the larger package for which Berroa was sentenced
    was a "mixture" according to the Rodriguez standards.
    Alternatively, Berroa argues that, even if the larger
    package constituted a "mixture or substance," it was not a
    "consumable," "marketable," or "ingestible" mixture of the
    type that numerous courts have determined that Congress
    and the Guidelines intended to punish. See Rodriguez, 
    975 F.2d at 1006
     ("Congress was concerned with mixtures that
    will eventually reach the streets--consumable mixtures.");
    United States v. Acosta, 
    963 F.2d 551
    , 553 (2d Cir. 1992)
    (determining that the Sentencing Guidelines do not require
    that "the weight of an unusable portion of a mixture, which
    makes the drugs uningestible and unmarketable, be
    included in the overall weight calculation"); United States v.
    Rolande-Gabriel, 
    938 F.2d 1231
    , 1237-38 (11th Cir. 1991)
    (holding that "liquid waste" packed and transported with
    cocaine was not to be considered part of the "mixture" used
    to calculate a defendant’s sentence, as the liquid was
    "unusable"). Berroa attempts to draw an analogy between
    these cases and his own by emphasizing, once again, the
    immeasurably small portion of controlled substance that
    was included in the larger bag in his case. He argues that
    this is not a "marketable" mixture since it is highly unlikely
    that such a disproportionately low ratio of drugs to"cut"
    was ever intended to be consumed or ingested, and that
    therefore, the entire weight of the larger bag should have
    been excluded in calculating his sentence underS 841(a)(1).
    We disagree. In analyzing the cases upon which he relies,
    Berroa ignores the single factor that was common to the
    determination of each: that in order for the substance in
    question to be marketable, ingestible, and/or consumable,
    either the distributor or the dealer first had to separate the
    controlled substance from the additional material. See
    Rodriguez, 
    975 F.2d at 1006
     (determining that block of
    boric acid and cocaine was not a "marketable mixture"
    10
    because, inter alia, the "boric acid functioned more like
    packaging material . . . from which the cocaine would have
    to be removed [in order to] use"); Acosta, 
    963 F.2d at 555
    ("[T]he ‘mixture’ here was useless because. . . [i]t could not
    be ingested or mixed with cutting agents unless and until
    the cocaine was distilled from the creme liqueur); United
    States v. Jennings 
    945 F.2d 129
    , 137-37 (6th Cir. 1991)
    (finding that the district court erred in including poisonous
    and other unusable parts of a methamphetamine mixture
    that would otherwise have to be distilled in order to be
    consumable); Rolande-Gabriel, 
    938 F.2d at 1237
    (distinguishing Chapman because the cocaine mixture at
    issue was easily separated from its liquid waste carrier
    medium and had to be separated for the drug to be
    consumed). The Second Circuit has explained that, in each
    of these cases, the non-drug portion of the mixture was
    "the functional equivalent of packaging material . . . which
    quite clearly is not to be included in the weight
    calculation." Acosta, 
    963 F.2d at
    554 (citing Chapman, 
    500 U.S. at 462-63
    ); see also U.S. Sentencing Guidelines
    Manual S 2D1.1, cmt. n.1 (adopting the reasoning of these
    cases by instructing that "[m]ixture or substance does not
    include materials that must be separated from the
    controlled substance before the controlled substance can be
    used").
    Conversely, common cutting agents such as procaine and
    lidocaine are added to heroin specifically to facilitate its use
    by addicts--thereby improving its ingestibility--and to
    increase its profitability for dealers and distributors--
    thereby enhancing its marketability. Because it was aware
    of this, Congress "clearly intended [that a] dilutant, cutting
    agent, or carrier medium be included in the weight of
    [drugs like heroin and cocaine] for sentencing purposes"
    even though "[i]n some cases, the concentration of the drug
    is very low." Chapman, 
    500 U.S. at 459-60
    . In Chapman,
    the Supreme Court noted that "Congress adopted a
    ‘market-oriented’ approach to punishing drug trafficking,
    under which the total quantity of what is distributed,
    rather than the amount of pure drug involved, is used to
    determine the length of the sentence." 
    Id. at 461
    . The Court
    observed that "Congress did not want to punish retail
    traffickers less severely, even though they deal in smaller
    11
    quantities of the pure drug, because such traffickers keep
    the street markets going." 
    Id.
     The Court further explained
    that Congress "intended the penalty for drug trafficking to
    be graduated according to the weight of the drugs in
    whatever form they were found--cut or uncut, pure or
    impure, ready for wholesale or ready for distribution at the
    retail level." 
    Id.
     Thus it is clear that a small amount of
    controlled substance combined with common cutting
    agents is a "marketable mixture" and the weight of the
    entire mixture must be included for sentencing purposes.
    We find that Congress’ "market-oriented approach" to
    punishing drug trafficking clearly implicates Berroa’s larger
    package that included a large quantity of procaine and
    lidocaine and only a trace of heroin.
    Berroa makes a related argument that a ‘trace’ of heroin
    is not a ‘detectable amount’ under the Guideline. Only one
    Circuit appears to have held that an infinitesimally small
    portion of controlled substance combined in a mixture with
    common cutting agents should not be considered under the
    Sentencing Guidelines. See United States v. Jackson, 
    115 F.3d 843
    , 848-49 (11th Cir. 1997) (holding that a package
    which contained 99 percent sugar and 1 percent cocaine
    was not a "marketable" mixture and that, therefore, only
    the net weight of the cocaine was relevant to determining a
    defendant’s sentence under the Sentencing Guidelines). To
    the extent that Berroa relies on Jackson, we disagree. The
    plain language of both the statute and the guidelines
    clearly indicates that the presence of "any detectable
    amount" of a controlled substance requires a sentencing
    court to consider the entire weight of a mixture. Webster’s
    Dictionary defines detectable as "capable of being detected"
    and defines "detect" as "to discover or determine the
    existence, presence or fact of." Webster’s Third New
    International Dictionary 616 (1993). While the initial field
    test in this case yielded negative results, subsequent
    laboratory tests indicated traces of heroin in the larger
    package. Since the lab test disclosed the existence or
    presence of at least some heroin, there was a "detectable"
    amount in the larger package.
    Finally, we note Berroa’s argument that a downward
    departure is warranted because the unusually low purity of
    12
    the heroin involved here places the case outside the
    heartland of cases covered under the guidelines. However,
    the District Court in fact granted Berroa a significant
    departure, finding that to do otherwise would "shock the
    conscience." App. at A 46. As we previously mentioned, in
    sentencing Berroa, the court first arrived at a Guideline
    sentencing range of 168-210 months, but then granted
    Berroa a substantial departure for "low drug purity" under
    U.S.S.G. S 2D1.1(b)(6). This departure resulted in a
    sentencing reduction of over 5 years. Berroa’s 100-month
    sentence, based on a mixture containing a very low amount
    of controlled substance, might appear inequitable. Yet the
    Court accounted for this concern. The Court’s sizeable
    downward departure for low drug purity mitigates any
    perceived unfairness here.7
    Accordingly, we hold that the traces of heroin disclosed
    during lab testing in this case, although in amounts too
    small to determine its purity within a mixture, constitute a
    detectable amount, and that the District Court did not err
    when it included the entire weight of the larger package in
    calculating Berroa’s sentence under U.S.S.G. S 2D1.1.
    IV.
    For the foregoing reasons, the judgment of the District
    Court is affirmed.
    A True Copy:
    Teste:
    Clerk of the United States Court of Appeals
    for the Third Circuit
    _________________________________________________________________
    7. As we previously noted, supra at n.3, the Government acknowledged
    the District Court’s discretion to depart downward based on low drug
    purity and does not challenge the court’s discretionary authority in this
    regard on appeal.
    13